These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 14844956)

  • 1. [Inhibition of the toxic power of folic acid antagonists].
    CANDEIAS JA
    Rev Clin Sao Paulo; 1951; 27(1-2):11-2. PubMed ID: 14844956
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic acid antagonists in therapy of leukemia and tumors; problem of resistance and relations with the citrovorum factor.
    PAOLINO W
    Minerva Med; 1952 Jun; 43(48):1296-1300. PubMed ID: 12982647
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the mechanism of action of chemotherapeutic agents in cancer. V. Influence of the citrovorum factor and folic acid on the toxic manifestations of aminopterin in mice.
    GREENSPAN EM; GOLDIN A; SCHOENBACH EB
    Cancer; 1951 May; 4(3):619-25. PubMed ID: 14839616
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the biological interrelationships of folic acid, citrovorum factor, and the antimetabolite, aminopterin.
    GOLDIN A; GREENSPAN EM; VENDITTI JM; SCHOENBACH EB
    J Natl Cancer Inst; 1952 Apr; 12(5):987-1002. PubMed ID: 14928052
    [No Abstract]   [Full Text] [Related]  

  • 5. The formation of citrovorum factor in the developing chick egg and the effect of injecting folic acid antagonists.
    SWENDSEID ME; JACKSON R; BENSON EM
    Arch Biochem Biophys; 1958 Nov; 78(1):221-6. PubMed ID: 13595920
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of aminopterin inhibition in the chick embryo with the Leuconostoc citrovorum factor.
    CRAVENS WW; SNELL EE
    Proc Soc Exp Biol Med; 1950 Oct; 75(1):43-5. PubMed ID: 14797730
    [No Abstract]   [Full Text] [Related]  

  • 7. Citrovorum factor; nutritional aspects, associations with leukemia and anemia.
    BAUMANN CA
    J Am Diet Assoc; 1953 Jun; 29(6):548-54. PubMed ID: 13061228
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of toxicity of massive doses of A-methopterin by citrovorum factor.
    BURCHENAL JH; BABCOCK GM
    Proc Soc Exp Biol Med; 1951 Feb; 76(2):382-4. PubMed ID: 14827933
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase of urinary citrovorum factor activity in patients receiving methotrexate (amethopterin).
    LI MC; NIXON WE; FREEMAN MV
    Proc Soc Exp Biol Med; 1958 Jan; 97(1):29-32. PubMed ID: 13518171
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous arterial infusion of methotrexate with intermittent, intramuscular citrovorum factor therapy in head and neck cancer.
    SULLIVAN RD
    Trans Pac Coast Otoophthalmol Soc Annu Meet; 1961; 42():29-42. PubMed ID: 13918329
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous intraarterial methotrexate with simultaneous, intermittent, intramuscular citrovorum factor herapy in carcinoma of the cervix.
    SULLIVAN RD; WOOD AM; CLIFFORD P; DUFF JK; TRUSSEL R; NARY DK; BURCHENAL JH
    Cancer Chemother Rep; 1960 Jul; 8():1-6. PubMed ID: 13835652
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of head and neck cancer with the continuous arterial infusion of methotrexate and the intermittent intramuscular administration of citrovorum factor.
    SULLIVAN RD; DALY JF
    Trans Am Laryngol Assoc; 1961; 82():54-72. PubMed ID: 13918323
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy.
    DUFF JK; SULLIVAN RD; MILLER E; ULM AH; CLARKSON BD; CLIFFORD P
    Cancer; 1961; 14():744-52. PubMed ID: 13724783
    [No Abstract]   [Full Text] [Related]  

  • 14. A growth factor for L. citrovorum synthesized by hemopoietic tissue reversing aminopterin and chloromycetin inhibition.
    SWENDSEID ME; WRIGHT PD; BETHELL FH
    Proc Soc Exp Biol Med; 1952; 80(4):689-90. PubMed ID: 12983383
    [No Abstract]   [Full Text] [Related]  

  • 15. Citrovorum factor and oviduct response to stilbestrol in aminopterin-treated chicks.
    KLINE IT; DORFMAN RI
    Proc Soc Exp Biol Med; 1951 Jan; 76(1):203-5. PubMed ID: 14816439
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of aminopterin and amethopterin toxicity by citrovorum factor.
    SCHOENBACH EB; GREENSPAN EM; COLSKY J
    J Am Med Assoc; 1950 Dec; 144(18):1558-60. PubMed ID: 14794378
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase.
    STOVNER J; ENGSETH A; BRENNHOVD I
    Cancer Chemother Rep; 1962 Aug; 21():147-8. PubMed ID: 13917570
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of chemotherapeutic effects of 4-amino-N10-methyl-pteroylglutamic acid on mouse leukemia by citrovorum factor.
    BURCHENAL JH; BABCOCK GM; BROQUIST HP; JUKES TH
    Proc Soc Exp Biol Med; 1950 Aug; 74(4):735-7. PubMed ID: 14781165
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of resistance to 4-amino n10-methyl pteroylglutamic acid (Amethopterin) by Leuconostoc citrovorum.
    HUTCHISON DJ; BURCHENAL JH
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):516-8. PubMed ID: 14949104
    [No Abstract]   [Full Text] [Related]  

  • 20. 2, 4-Diaminopyrimidines as antagonists of folic acid and folinic acid.
    HITCHINGS GH; FALCO EA; ELION GB; SINGER S; WARING GB; HUTCHISON DJ; BURCHENAL JH
    Arch Biochem Biophys; 1952 Oct; 40(2):479-81. PubMed ID: 12997239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.